Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 24

Sort by

Sort Order Select

Journal Articles

Ywhae Located on Chromosome 17p13 Promotes Myeloma Cells Proliferation Via Induction of Anti-Apoptosis and Survival Signaling Pathways

Blood (2017) 130 (Supplement 1): 1755.

https://doi.org/10.1182/blood.V130.Suppl_1.1755.1755

Published: 2017

Journal Articles

SF3B1 Mutations in AML, MDS and MDS/MPN-RS-T Are Accompanied By Different Other Gene Mutations: Impact for Targeted Treatment Studies

Manja Meggendorfer, PhD, Sabine Jeromin, PhD, Karolína Perglerová, Claudia Haferlach, MD, Wolfgang Kern, MD, Torsten Haferlach, MD

Blood (2016) 128 (22): 1976.

https://doi.org/10.1182/blood.V128.22.1976.1976

Published: 2016

Journal Articles

Synthetic Lethality In CLL With DNA Damage Response Defect By Targeting ATR Pathway

Tatjana Stankovic, MD, PhD, Davies Nicholas, Marwan Kwok, Edward Smith, Eliot Yates, Angelo Agathanggelou, Brown Jeff, Alan Lau

Blood (2013) 122 (21): 120.

https://doi.org/10.1182/blood.V122.21.120.120

Published: 2013

Journal Articles

Defects of ATM Gene Involving Mutation Lead to Complete Elimination of ATM Function in Chronic Lymphocytic Leukemia

Veronika Navrkalova, MSc., Ludmila Sebejova, Dr., Jana Zemanova, Jana Kminkova, PharmD., Blanka Kubesova, Michael Doubek, Prof., Yvona Brychtova, M.D., Ph.D., Jana Smardova, Prof., Jiri Mayer, M.D., PhD., Prof., Sarka Pospisilova, Prof., Martin Trbusek, PhD

Blood (2012) 120 (21): 3902.

https://doi.org/10.1182/blood.V120.21.3902.3902

Published: 2012

Journal Articles

Deletion 11q Abnormality in Patients with Chronic Lymphocytic Leukemia (CLL) May Not Have Poor Clinical Outcomes and Bulky Disease (clinical and radiological) At Presentation – Clinical Characteristics of (n=172) Previously Untreated Patients with CLL and del11q Cytogenetic Abnormality.

Preetesh Jain, MD, DM, PhD, Long Xuan Trinh, Ohad Benjamini, MD, Susan Lerner, MS, Xuemei Wang, MS, Alessandra Ferrajoli, MD, Jan A. Burger, MD, PhD, Zeev Estrov, MD, PhD, William G. Wierda, MD, PhD, Hagop M. Kantarjian, MD, Susan O'Brien, M.D., Lynne V. Abruzzo, MD, PhD, Michael J. Keating, MD

Blood (2012) 120 (21): 2890.

https://doi.org/10.1182/blood.V120.21.2890.2890

Published: 2012

Journal Articles

New Therapeutic Strategy for Sensitisation of CLL Cells with Inactivation of the DNA Damage Response by Targeting the Deubiquitylating Enzyme USP7-Dependent Pathways,

Angelo Agathanggelou, PhD, Anastasia Zlatanou, PhD, Ahmed Gulshanara, MSc, Grant Stewart, PhD, Pamela R Kearns, BSc, MBBCh, MRCP, PhD, Guy Pratt, MD, Paul AH Moss, MD PhD, A. Malcolm R Taylor, PhD, Frederic Colland, PhD, Tatjana Stankovic, MD, PhD

Blood (2011) 118 (21): 3865.

https://doi.org/10.1182/blood.V118.21.3865.3865

Published: 2011

Journal Articles

Integrated Genome-Wide CTCF and Cohesin SA1 Occupancy and Expression Analyses in Erythropoiesis

Vincent P Schulz, PhD, Laurie A. Steiner, MD, Yelena Maksimova, Patrick G. Gallagher, MD

Blood (2011) 118 (21): 1305.

https://doi.org/10.1182/blood.V118.21.1305.1305

Published: 2011

Journal Articles

Chd7 Is a Cell Autonomous Regulator of Chromatin In Hematopoietic Stem Cells.

Hsuan-Ting Huang, Katie Kathrein, Ph.D., Yue-Hua Huang, Zachary Gitlin, Abby Barton, Anhua Song, Yi Zhou, Ph.D., Leonard I. Zon, MD

Blood (2010) 116 (21): 1596.

https://doi.org/10.1182/blood.V116.21.1596.1596

Published: 2010

Journal Articles

Sequential SNP6.0 Microarray Analysis In Rai Stage 0 CLL Patients with Either Stable or Progressive Identifies Genomic Evolution In Both Cohorts

Matthew JJ Rose-Zerilli, PhD, Miqdad Rajibali, BSc, Helen Parker, PhD, Anton Parker, BSc, Anne Catherine Gardiner, BSc, Zadie Davis, PhD, Sarah Mold, BSc, Sharron Glide, BSc, Tracy Chaplin, Bryan D Young, BSc, PhD, David Graham Oscier, Jonathan C. Strefford, BSc, PhD

Blood (2010) 116 (21): 1696.

https://doi.org/10.1182/blood.V116.21.1696.1696

Published: 2010

Journal Articles

ATM Gene Point Mutation and Frameshift Mutation Are Found In High-Risk, Untreated Chronic Lymphocytic Leukemia Patients with Interstitial Deletion of Chromosome 11q and Uniparental Disomy of Chromosome 11q

Steven A. Schichman, MD, PhD, Jennifer H. Han, MS, Juan-Sebastian Saldivar, MD, FACMG, Annjanette Stone, BS, Maria Winters, MPH, Weleetka Carter, BS, Lori Frederick, BS, David S. Viswanatha, MD, Clive S. Zent, MD

Blood (2010) 116 (21): 2420.

https://doi.org/10.1182/blood.V116.21.2420.2420

Published: 2010

Journal Articles

Increased Frequency of Constitutional Pathogenic ATM Mutations in CLL Patients Compared to Control Individuals Suggests An Aetiological Role.

Tatjana Stankovic, MD.PhD, Belinda Austen, Guy Pratt, Anna Skowronska, David Oscier, Martin JS Dyer, Estella Matutes, MD, PhD, Malcolm Taylor, Paul Moss, MBBS, PhD, FRCP

Blood (2009) 114 (22): 1250.

https://doi.org/10.1182/blood.V114.22.1250.1250

Published: 2009

Journal Articles

ATM Gene Alterations in CLL Patients Induce Gene Profile Clusters and Predict Disease Progression.

Anna Guarini, Marilisa Marinelli, Simona Tavolaro, Isabella Torrente, Emanuele Bellacchio, Monia Magliozzi, Simona Santangelo, Nadia Peragine, Maria Stefania De Propris, Mauro Nanni, Sabina Chiaretti, Francesca Romana Mauro, Ilaria Del Giudice, Bruno Dallapiccola, Robert Foa

Blood (2008) 112 (11): 2084.

https://doi.org/10.1182/blood.V112.11.2084.2084

Published: 2008

Journal Articles

Ataxia Telangiectasia Mutated (ATM) Gene Expression Is Reversibly Up-Regulated in FANCA -Mutant Patient Fibroblasts by an Indirect Mechanism.

Johnson M. Liu, MD, Abdallah Nihrane, PhD, Kazuhiko Yamamoto, MD, PhD

Blood (2007) 110 (11): 1679.

https://doi.org/10.1182/blood.V110.11.1679.1679

Published: 2007

Journal Articles

Chromosomal Evolution in B-Cell Chronic Lymphocytic Leukemia (B-CLL).

Paolo Bernasconi, MD, Ilaria Giardini, MD, Ester Orlandi, MD, Marina Boni, MD, Paola Maria Cavigliano, MD, Silvia Calatroni, MD, Barbara Rocca, MD, Rita Zappatore, MD, Irene Dambruoso, MD, Marilena Caresana, MD, Mario Lazzarino, MD

Blood (2006) 108 (11): 4933.

https://doi.org/10.1182/blood.V108.11.4933.4933

Published: 2006

Journal Articles

Mutations in the ATM gene lead to impaired overall and treatment-free survival that is independent of IGVH mutation status in patients with B-CLL

Belinda Austen, Judith E. Powell, Azra Alvi, Ian Edwards, Laura Hooper, Jane Starczynski, A. Malcolm R. Taylor, Christopher Fegan, Paul Moss, Tatjana Stankovic

Blood (2005) 106 (9): 3175–3182.

https://doi.org/10.1182/blood-2004-11-4516

Published: 2005

Journal Articles

Mantle-cell lymphoma genotypes identified with CGH to BAC microarrays define a leukemic subgroup of disease and predict patient outcome

Fanny Rubio-Moscardo, Joan Climent, Reiner Siebert, Miguel A. Piris, Jose I. Martín-Subero, Inga Nieländer, Javier Garcia-Conde, Martin J. S. Dyer, Maria Jose Terol, Daniel Pinkel, Jose A. Martinez-Climent

Blood (2005) 105 (11): 4445–4454.

https://doi.org/10.1182/blood-2004-10-3907

Published: 2005

Includes: Supplemental data

Journal Articles

ATM Mutations Define a Subset of B-CLL Tumours That Only Partially Correlates with 11q Status and Is Associated with Impaired Patient Survival.

Belinda Austen, MRCP, Christopher Fegan, MD, MRCP, MRCPath, Paul Moss, Phd,MRCP,MRCPath, Tanja Stankovic, Phd

Blood (2004) 104 (11): 774.

https://doi.org/10.1182/blood.V104.11.774.774

Published: 2004

Journal Articles

Identification and characterization of polymorphic variations of the ataxia telangiectasia mutated ( ATM ) gene in childhood Hodgkin disease

Masatoshi Takagi, Rika Tsuchida, Kaoru Oguchi, Teruko Shigeta, Shinichiro Nakada, Kimiko Shimizu, Misao Ohki, Domenico Delia, Luciana Chessa, Yoichi Taya, Makoto Nakanishi, Yukiko Tsunematsu, Fumio Bessho, Keiichi Isoyama, Yoshiki Hayashi, Kazuko Kudo, Jun Okamura, Shuki Mizutani

Blood (2004) 103 (1): 283–290.

https://doi.org/10.1182/blood-2003-01-0094

Published: 2004

Journal Articles

ATM mutations are associated with inactivation of the ARF - TP53 tumor suppressor pathway in diffuse large B-cell lymphoma

Kirsten Grønbæk, Jesper Worm, Elisabeth Ralfkiaer, Vibeke Ahrenkiel, Peter Hokland, Per Guldberg

Blood (2002) 100 (4): 1430–1437.

https://doi.org/10.1182/blood-2002-02-0382

Published: 2002

Journal Articles

ATM mutations are rare in familial chronic lymphocytic leukemia

Martin R. Yuille, Alison Condie, Chantelle D. Hudson, Paul S. Bradshaw, Elaine M. Stone, Estella Matutes, Daniel Catovsky, Richard S. Houlston

Blood (2002) 100 (2): 603–609.

https://doi.org/10.1182/blood.V100.2.603

Published: 2002

NARROW

Ywhae Located on Chromosome 17p13 Promotes Myeloma Cells Proliferation Via Induction of Anti-Apoptosis and Survival Signaling Pathways

SF3B1 Mutations in AML, MDS and MDS/MPN-RS-T Are Accompanied By Different Other Gene Mutations: Impact for Targeted Treatment Studies

Synthetic Lethality In CLL With DNA Damage Response Defect By Targeting ATR Pathway

Defects of ATM Gene Involving Mutation Lead to Complete Elimination of ATM Function in Chronic Lymphocytic Leukemia

Deletion 11q Abnormality in Patients with Chronic Lymphocytic Leukemia (CLL) May Not Have Poor Clinical Outcomes and Bulky Disease (clinical and radiological) At Presentation – Clinical Characteristics of (n=172) Previously Untreated Patients with CLL and del11q Cytogenetic Abnormality.

New Therapeutic Strategy for Sensitisation of CLL Cells with Inactivation of the DNA Damage Response by Targeting the Deubiquitylating Enzyme USP7-Dependent Pathways,

Integrated Genome-Wide CTCF and Cohesin SA1 Occupancy and Expression Analyses in Erythropoiesis

Chd7 Is a Cell Autonomous Regulator of Chromatin In Hematopoietic Stem Cells.

Sequential SNP6.0 Microarray Analysis In Rai Stage 0 CLL Patients with Either Stable or Progressive Identifies Genomic Evolution In Both Cohorts

ATM Gene Point Mutation and Frameshift Mutation Are Found In High-Risk, Untreated Chronic Lymphocytic Leukemia Patients with Interstitial Deletion of Chromosome 11q and Uniparental Disomy of Chromosome 11q

Increased Frequency of Constitutional Pathogenic ATM Mutations in CLL Patients Compared to Control Individuals Suggests An Aetiological Role.

ATM Gene Alterations in CLL Patients Induce Gene Profile Clusters and Predict Disease Progression.

Ataxia Telangiectasia Mutated (ATM) Gene Expression Is Reversibly Up-Regulated in FANCA -Mutant Patient Fibroblasts by an Indirect Mechanism.

Chromosomal Evolution in B-Cell Chronic Lymphocytic Leukemia (B-CLL).

Mutations in the ATM gene lead to impaired overall and treatment-free survival that is independent of IGVH mutation status in patients with B-CLL

Mantle-cell lymphoma genotypes identified with CGH to BAC microarrays define a leukemic subgroup of disease and predict patient outcome

ATM Mutations Define a Subset of B-CLL Tumours That Only Partially Correlates with 11q Status and Is Associated with Impaired Patient Survival.

Identification and characterization of polymorphic variations of the ataxia telangiectasia mutated ( ATM ) gene in childhood Hodgkin disease

ATM mutations are associated with inactivation of the ARF - TP53 tumor suppressor pathway in diffuse large B-cell lymphoma

ATM mutations are rare in familial chronic lymphocytic leukemia

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only